Allergy Treatment Market Overview :
The global allergy treatment market was valued at $24,653 million in 2017, and is expected to reach $40,360 million by 2025, registering a CAGR of 6.3% from 2018 to 2025.
Allergy is a major health concern across the globe. An allergic reaction is a hypersensitive response of the immune system to the allergens present in the environment. Substances or allergens, which are more potent to cause an allergic reaction include mold, grass, pollen grains, peanut, egg, soy, and others. In addition, according to the WHO, by 2050, 1 in 2 people are expected to suffer from allergies. Further, the American Academy of Allergy Asthma and Immunology concluded that the rise in prevalence of allergies in the industrialized world is estimated to continue for more than 50 years worldwide. This is predicted to boost the growth of the allergy treatment market.
Rise in preference toward over-the-counter drugs for allergy treatment and surge in self-medication by consumers are the major factors that drive the market growth. In addition, innovative developments in the field of allergy immunotherapy (AIT) such as advent of sub-lingual, allergen specific immunotherapy, further accelerate the growth of the global allergy treatment market. However, increased preference toward the use of biosimilars to treat allergies and safety & efficacy concerns regarding the side effects of anti-allergy drugs are anticipated to hamper the growth of the allergy treatment market. On the contrary, increased R&D investments by the manufacturers toward the development of novel anti-allergy treatment medications is expected to create lucrative opportunities in future.
The global allergy treatment market is segmented based on type, treatment, dosage form, and distribution channels. Based on type, the market is divided into eye allergy, skin allergy, food allergy, rhinitis, asthma, and others. Based on treatment, the market is bifurcated into anti-allergy drugs and immunotherapy. Based on dosage form, it is classified into oral, intranasal, inhalers, and others. Based on distribution channel, it is classified into hospital pharmacies, retail pharmacies, online retailers, and others. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for Allergy Treatment Market :
The study provides an in-depth analysis of the global allergy treatment market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the global trends in the allergy treatment market.
Key players and their strategies are provided to understand the competitive outlook of the industry.
Allergy Treatment Key Market Segments :
By Type
Eye Allergy
Skin Allergy
Food Allergy
Rhinitis
Asthma
Others
By Treatment
Anti-Allergy Drugs
Immunotherapy
By Dosage Form
Oral
Intranasal
Inhalers
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Retailers
Others
By Region
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
France
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Saudi Arabia
South Africa
Brazil
Turkey
Rest of LAMEA
Key Market Players
Merck KGaA (Allergopharma)
GlaxoSmithKline
Allergy Therapeutics
F. Hoffmann-La Roche AG
Merck Co. & Inc.
ALK-Abelló A/S
Sallergenes Greer
Allergan plc
Sanofi SA
Johnson & Johnson
The other players in the value chain include (profiles not included in the report)
NOVARTIS AG
Sunovion Pharmaceuticals Inc
HAL Allergy Group
Collegium Pharmaceutical, Inc.
Procter & Gamble
Circassia
Mylan NV
Teva Pharmaceuticals
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top Winning Strategies
3.3. Porters five forces analysis
3.4. Market share analysis, 2017
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. The rising importance for self-medication
3.5.1.2. Increase in incidence of food allergies across the globe
3.5.1.3. Increased investment by the manufacturers on the development of novel allergic treatments
3.5.2. Restraints
3.5.2.1. Rise in preference towards the use of biosimilars
3.5.2.2. Low awareness of allergy immunotherapy (AIT) among patients
3.5.3. Opportunity
3.5.3.1. Innovative developments in the field of immunotherapy
CHAPTER 4: ALLERGY TREATMENT MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Eye allergy
4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Rhinitis
4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Asthma
4.4.1. Key trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Skin Allergy
4.5.1. Key trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Food Allergies
4.6.1. Key trends and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
4.7. Other Allergies
4.7.1. Key trends and opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country
CHAPTER 5: ALLERGY TREATMENT MARKET, BY TREATMENT
5.1. Overview
5.1.1. Market size and forecast
5.2. Anti-Allergy Drugs
5.2.1. Market size and forecast
5.2.2. Antihistamines
5.2.2.1. Market size and forecast
5.2.3. Corticosteroids
5.2.3.1. Market size and forecast
5.2.4. Decongestants
5.2.4.1. Market size and forecast
5.2.5. Other Drugs
5.2.5.1. Market size and forecast
5.3. Immunotherapy
5.3.1. Market size and forecast
5.3.2. Subcutaneous Immunotherapy (SCIT)
5.3.2.1. Market size and forecast
5.3.3. Sun-Lingual Immunotherapy (SLIT)
5.3.3.1. Market size and forecast
CHAPTER 6: ALLERGY TREATMENT MARKET, BY DOSAGE FORM
6.1. Overview
6.1.1. Market size and forecast
6.2. Oral
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Inhalers
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Intranasal
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Others
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
CHAPTER 7: ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL
7.1. Overview
7.1.1. Market size and forecast
7.2. Retail pharmacies
7.2.1. Market size and forecast
7.3. Hospital Pharmacies
7.3.1. Market size and forecast
7.4. Online Retailers
7.4.1. Market size and forecast
7.5. Others
7.5.1. Market size and forecast
CHAPTER 8: ALLERGY TREATMENT MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. North America market size and forecast, by country
8.2.2.1. U.S. market size and forecast, by type
8.2.2.2. U.S. market size and forecast, by treatment
8.2.2.3. U.S. market size and forecast, by dosage form
8.2.2.4. U.S. market size and forecast, by distribution channel
8.2.2.5. Canada market size and forecast, by type
8.2.2.6. Canada market size and forecast, by treatment
8.2.2.7. Canada market size and forecast, by dosage form
8.2.2.8. Canada market size and forecast, by distribution channel
8.2.2.9. Mexico market size and forecast, by type
8.2.2.10. Mexico market size and forecast, by treatment
8.2.2.11. Mexico market size and forecast, by dosage form
8.2.2.12. Mexico market size and forecast, by distribution channel
8.2.3. North America market size and forecast, by type
8.2.4. North America market size and forecast, by treatment
8.2.5. North America market size and forecast, by dosage form
8.2.6. North America market size and forecast, by distribution channel
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Europe market size and forecast, by country
8.3.2.1. Germany market size and forecast, by type
8.3.2.2. Germany market size and forecast, by treatment
8.3.2.3. Germany market size and forecast, by dosage form
8.3.2.4. Germany market size and forecast, by distribution channel
8.3.2.5. UK market size and forecast, by type
8.3.2.6. UK market size and forecast, by treatment
8.3.2.7. UK market size and forecast, by dosage form
8.3.2.8. UK market size and forecast, by distribution channel
8.3.2.9. France market size and forecast, by type
8.3.2.10. France market size and forecast, by treatment
8.3.2.12. France market size and forecast, by dosage form
8.3.2.13. France market size and forecast, by distribution channel
8.3.2.14. Rest of Europe market size and forecast, by Type
8.3.2.15. Rest of Europe market size and forecast, by treatment
8.3.2.16. Rest of Europe market size and forecast, by dosage form
8.3.2.17. Rest of Europe market size and forecast, by distribution channel
8.3.3. Europe market size and forecast, by type
8.3.4. Europe market size and forecast, by treatment
8.3.5. Europe market size and forecast, by dosage form
8.3.6. Europe market size and forecast, by distribution channel
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Asia-Pacific market size and forecast, by country
8.4.2.1. Japan market size and forecast, by type
8.4.2.2. Japan market size and forecast, by treatment
8.4.2.3. Japan market size and forecast, by dosage form
8.4.2.4. Japan market size and forecast, by distribution channel
8.4.2.5. China market size and forecast, by type
8.4.2.6. China market size and forecast, by treatment
8.4.2.7. China market size and forecast, by dosage form
8.4.2.8. China market size and forecast, by distribution channel
8.4.2.9. India market size and forecast, by type
8.4.2.10. India market size and forecast, by treatment
8.4.2.11. India market size and forecast, by dosage form
8.4.2.12. India market size and forecast, by distribution channel
8.4.2.13. Australia market size and forecast, by type
8.4.2.14. Australia market size and forecast, by treatment
8.4.2.15. Australia market size and forecast, by dosage form
8.4.2.16. Australia market size and forecast, by distribution channel
8.4.2.17. Rest of Asia-Pacific market size and forecast, by type
8.4.2.18. Rest of Asia-Pacific market size and forecast, by treatment
8.4.2.19. Rest of Asia-Pacific market size and forecast, by dosage form
8.4.2.20. Rest of Asia-Pacific market size and forecast, by distribution channel
8.4.3. South Korea market size and forecast, by type
8.4.4. South Korea market size and forecast, by treatment
8.4.5. South Korea market size and forecast, by dosage form
8.4.6. South Korea market size and forecast, by distribution channel
8.4.7. Asia-Pacific market size and forecast, by type
8.4.8. Asia-Pacific market size and forecast, by treatment
8.4.9. Asia-Pacific market size and forecast, by dosage form
8.4.10. Asia-Pacific market size and forecast, by distribution channel
8.1. LAMEA
8.1.1. Key market trends and opportunities
8.1.2. Asia-Pacific market size and forecast, by country
8.1.2.1. Brazil market size and forecast, by type
8.1.2.2. Brazil market size and forecast, by treatment
8.1.2.3. Brazil market size and forecast, by dosage form
8.1.2.4. Brazil market size and forecast, by distribution channel
8.1.2.5. South Africa market size and forecast, by type
8.1.2.6. South Africa market size and forecast, by treatment
8.1.2.7. South Africa market size and forecast, by dosage form
8.1.2.8. South Africa market size and forecast, by distribution channel
8.1.2.9. Saudi Arabia market size and forecast, by type
8.1.2.10. Saudi Arabia market size and forecast, by treatment
8.1.2.11. Saudi Arabia market size and forecast, by dosage form
8.1.2.12. Saudi Arabia market size and forecast, by distribution channel
8.1.2.13. Turkey market size and forecast, by type
8.1.2.14. Turkey market size and forecast, by treatment
8.1.2.15. Turkey market size and forecast, by dosage form
8.1.2.16. Turkey market size and forecast, by distribution channel
8.1.2.17. Rest of LAMEA market size and forecast, by type
8.1.2.18. Rest of LAMEA market size and forecast, by treatment
8.1.2.19. Rest of LAMEA market size and forecast, by dosage form
8.1.2.20. Rest of LAMEA market size and forecast, by distribution channel
8.1.2.21. LAMEA market size and forecast, by type
8.1.2.22. LAMEA market size and forecast, by treatment
8.1.2.23. LAMEA market size and forecast, by dosage form
8.1.2.24. LAMEA market size and forecast, by distribution channel
CHAPTER 9: COMPANY PROFILES
9.1. Merck KGaA (Allergopharma)
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.1.6. Key strategic moves and developments
9.2. GlaxoSmithKline plc
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.3. F. Hoffmann-La Roche Ltd. (Genentech Inc.)
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments
9.4. Johnson & Johnson
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. Allergy Therapeutics plc
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.6. AALK-Abello A/S
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments
9.7. Sanofi SA
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments
9.8. Stallergenes Greer plc
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.8.6. Key strategic moves and developments
9.9. Allergan Plc.
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.10. Merck & Co. Inc.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
LIST OF TABLES
TABLE 01. GLOBAL ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 02. GLOBAL EYE ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 03. GLOBAL RHINITIS ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 04. GLOBAL ASTHMA ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 05. GLOBAL SKIN ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 06. GLOBAL FOOD ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 07. GLOBAL OTHER ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 08. GLOBAL ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 09. GLOBAL ALLERGY TREATMENT MARKET, FOR ANTI-ALLERGY DRUGS, BY REGION, 20172025 ($MILLION)
TABLE 10. GLOBAL IMMNUNOTHERAPY ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 11. GLOBAL ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 12. ALLERGY TREATMENT MARKET, FOR ORAL DOSGE FORM, BY REGION, 20172025 ($MILLION)
TABLE 13. ALLERGY TREATMENT MARKET, FOR INHALERS, BY REGION, 20172025 ($MILLION)
REGION
TABLE 14. INHALERS MARKET, BY REGION, 20172025 ($MILLION)
REGION
TABLE 15. INHALERS MARKET, BY REGION, 20172025 ($MILLION)
REGION
TABLE 16. GLOBAL ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 17. GLOBAL ALLERGY TREATMENT MARKET, FOR RETAIL PHARMACIES BY REGION, 20172025 ($MILLION)
TABLE 18. GLOBAL ALLERGY TREATMENT MARKET, FOR DRUG STORES, BY REGION, 20172025 ($MILLION)
TABLE 19. GLOBAL ALLERGY TREATMENT MARKET, FOR ONLINE RETAILERS, BY REGION, 20172025 ($MILLION)
TABLE 20. GLOBAL ALLERGY TREATMENT MARKET, FOR OTHERS BY REGION, 20172025 ($MILLION)
TABLE 21. GLOBAL ALLERGY TREATMENT MARKET, BY REGION, 20172025 ($MILLION)
TABLE 22. NORTH AMERICA ALLERGY TREATMENT MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 23. U.S. ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 24. U.S. ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 25. U.S. ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 26. U.S. ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 27. CANADA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 28. CANADA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 29. CANADA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 30. CANADA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 31. MEXICO ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 32. MEXICO ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 33. MEXICO ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 34. MEXICO ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 35. NORTH AMERICA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 36. NORTH AMERICA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 37. NORTH AMERICA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 38. NORTH AMERICA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL 20172025 ($MILLION)
TABLE 39. EUROPE ALLERGY TREATMENT MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 40. GERMANY ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 41. GERMANY ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 42. GERMANY ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 43. GERMANY ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 44. UK ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 45. UK ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 46. UK ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 47. UK ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 48. FRANCE ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 49. FRANCE ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 50. FRANCE ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 51. FRANCE ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 52. REST OF EUROPE ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 53. REST OF EUROPE ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 54. REST OF EUROPE ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 55. REST OF EUROPE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 56. EUROPE ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 57. EUROPE ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 58. EUROPE ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 59. EUROPE ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 60. ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 61. JAPAN ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 62. JAPAN ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 63. JAPAN ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 64. JAPAN ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 65. CHINA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 66. CHINA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 67. CHINA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 68. CHINA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 69. INDIA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 70. INDIA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 71. INDIA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 72. INDIA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 73. AUSTRALIA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 74. AUSTRALIA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 75. AUSTRALIA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 76. AUSTRALIA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 77. REST OF ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 78. REST OF ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 79. REST OF ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 80. REST OF ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 81. EUROPE ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 82. SOUTH KOREA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 83. SOUTH KOREA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 84. SOUTH KOREA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 85. ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 86. ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 87. ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 88. ASIA-PACIFIC ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 01. LAMEA ALLERY TREATMENT MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 02. BRAZIL ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 03. BRAZIL ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 04. BRAZIL ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 05. SOUTH AFRICA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 06. SOUTH AFRICA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 07. SOUTH AFRICA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 08. SOUTH AFRICA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 09. SOUTH AFRICA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 10. SAUDI ARABIA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 11. SAUDI ARABIA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 12. SAUDI ARABIA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 13. SAUDI ARABIA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 14. TURKEY ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 15. TURKEY ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 16. TURKEY ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 17. TURKEY ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 18. REST OF LAMEA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 19. REST OF LAMEA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 20. REST OF LAMEA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 21. REST OF LAMEA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 22. LAMEA ALLERGY TREATMENT MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 23. LAMEA ALLERGY TREATMENT MARKET, BY TREATMENT, 20172025 ($MILLION)
TABLE 24. LAMEA ALLERGY TREATMENT MARKET, BY DOSAGE FORM, 20172025 ($MILLION)
TABLE 25. LAMEA ALLERGY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 20172025 ($MILLION)
TABLE 26. MERCK: COMPANY SNAPSHOT
TABLE 27. MERCK: OPERATING SEGMENTS
TABLE 28. MERCK: PRODUCT PORTFOLIO
TABLE 29. GSK: COMPANY SNAPSHOT
TABLE 30. GSK: OPERATING SEGMENTS
TABLE 31. GSK: PRODUCT PORTFOLIO
TABLE 32. ROCHE: COMPANY SNAPSHOT
TABLE 33. ROCHE: OPERATING SEGMENTS
TABLE 34. ROCHE: PRODUCT PORTFOLIO
TABLE 35. J&J: COMPANY SNAPSHOT
TABLE 36. J&J: OPERATING SEGMENTS
TABLE 37. J & J: PRODUCT PORTFOLIO
TABLE 38. ALLERGY THERAPEUTICS: COMPANY SNAPSHOT
TABLE 39. ALLERGY THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 40. ALK: COMPANY SNAPSHOT
TABLE 41. ALK: OPERATING SEGMENTS
TABLE 42. ALK: PRODUCT PORTFOLIO
TABLE 43. SANOFI: COMPANY SNAPSHOT
TABLE 44. SANOFI: OPERATING SEGMENTS
TABLE 45. SANOFI: PRODUCT PORTFOLIO
TABLE 46. STALLERGENES: COMPANY SNAPSHOT
TABLE 47. STALLERGENES: OPERATING SEGMENTS
TABLE 48. STALLERGENES: PRODUCT PORTFOLIO
TABLE 49. ALLERGAN: COMPANY SNAPSHOT
TABLE 50. ALLERGAN: OPERATING SEGMENTS
TABLE 51. ALLERGAN: PRODUCT PORTFOLIO
TABLE 52. MERCK: COMPANY SNAPSHOT
TABLE 53. MERCK: OPERATING SEGMENTS
TABLE 54. MERK: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. ALLERGY TREATMENT MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS, 2017
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2015-2018*
FIGURE 06. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 07. HIGH BARGAINING POWER OF BUYERS
FIGURE 08. HIGH THREAT OF SUBSTITUTION
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. HIGH COMPETITIVE RIVALRY
FIGURE 11. MARKET SHARE ANALYSIS, 2017
FIGURE 12. GLOBAL ALLERGY TREATMENT MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 19. GLOBAL ALLERGY TREATMENT MARKET FOR ANTIHISTAMINES, 20172025 ($MILLION)
FIGURE 20. GLOBAL ALLERGY TREATMENT MARKET FOR CORTICOSTEROIDS, 20172025 ($MILLION)
FIGURE 21. GLOBAL ALLERGY TREATMENT MARKET FOR DECONGESTANTS, 20172025 ($MILLION)
FIGURE 22. GLOBAL ALLERGY TREATMENT MARKET, FOR OTHER DRUGS, 20172025 ($MILLION)
FIGURE 23. GLOBAL ALLERGY TREATMENT MARKET FOR OTHER DRUGS, 20172025 ($MILLION)
FIGURE 24. GLOBAL ALLERGY TREATMENT MARKET FOR OTHER DRUGS, 20172025 ($MILLION)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR DOSAGE FORM, BY COUNTRY, 2017 & 2025 (%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR INHALER, BY COUNTRY, 2017 & 2025 (%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR INHALERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF ALLERGY TREATMENT MARKET, FOR OTHERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 29. MERCK: REVENUE, 20152017 ($MILLION)
FIGURE 30. MERCK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 31. MERCK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 32. GSK: NET SALES, 20152017 ($MILLION)
FIGURE 33. GSK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 34. GSK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 35. ROCHE: NET SALES, 20152017 ($MILLION)
FIGURE 36. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 37. J&J: NET SALES, 20172016 ($MILLION)
FIGURE 38. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 39. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 40. ALLERGY THERAPEUTICS: NET SALES, 20152017 ($MILLION)
FIGURE 41. ALK: NET SALES, 20152017 ($MILLION)
FIGURE 42. ALK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 43. ALK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 44. SANOFI: NET SALES, 20152017 ($MILLION)
FIGURE 45. SANOFI: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 46. SANOFI: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 47. STALLERGENES: REVENUE, 20152017 ($MILLION)
FIGURE 48. STALLERGENES: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 49. STALLERGENES: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 50. ALLERGAN: NET SALES, 20152017 ($MILLION)
FIGURE 51. ALLERGAN: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 52. MERCK: NET SALES, 20152016 ($MILLION)
FIGURE 53. MERCK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 54. MERCK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
Research Methodology
It is a well-organized procedure to carry out research. We at Market Growth Insight follow global, all-inclusive & iterative research methodology to develop our research reports. We are using both the top down as well as bottom-up approaches for partitioning and evaluating the significant aspects of the market.
It is a systematic & strategic approach for conducting a market study. Our market research methodology is based on the concept that gives a detailed description of the factors behind an observation. Let us see the detailed market research methodology.
Primary Data Research
It is the very basic stage of research the raw data is obtained and collected on a boarded front.Data is constantly filtered to ensure that only validated and authenticated sources are considered. Moreover,information is also mined from a large group of reports in our vault, as well as various reputed paid databases. It is necessary to understand the entire value chain and in order to facilitate this; we gather information from raw material suppliers, distributors as well as buyers, for extensive knowledge of the market.
The technical issues and trends are acquired from reviews, technical discussion and trade journals. Moreover, the technical data is also accumulated from intellectual property prospective, focusing on a void area and freedom of movement. The industry elements regarding drivers, restraints, pricing trends are also collected. Subsequently, the material developed contains a wide range of original and unique information that is then further cross-validated and authenticated with published sources.
Statistical Model
Simulation models are responsible to estimate and forecast our market, and for each research, a unique model is created and customized. The data accumulated for market dynamics, innovation scene, application improvement, estimating trends is delivered into the model and analyzedsimultaneously. These components are examined on a comparative basis, and their impact on the figure of the frame is measured with the assistance of correlation, regression and time series investigation. Forecasting of the market is performed through the consolidation of economic tools, innovative examination, and industry experience along with domain expertise. Generally, economic models are utilized for short-termforecasting, technological market models are used for long-term forecasting of a market. These are based on an amalgamation of technology innovation, regulatory frameworks, economic outlook, and business principles. A bottom-up approach to the market estimation is preferred, with key regional markets analyzed as separate entities and integration of information to get a worldwide evaluation. This is very critical for a deep knowledge of the business as well as ensuring negligible mistakes. Below mentioned are some of the parameters are considered for forecasting
Market drivers and restraints, along with their current and expected impact
Raw material scenario and supply v/s price trends
Regulatory situation and expected developments
Current capacity and expected capacity additions up to 2025
Market driving organizations
The key targets of essential research are as per the following
To approve our information as far as exactness and adequacy
To pick up an understanding of the present market and future desires
We dole out weights to these parameters and evaluate their market effect utilizing weighted normal examination, to infer a normal market development rate.
This is the last advance in assessing and anticipating for our reports. Thorough essential meetings are led, on up close and personal and additionally via telephone to approve our discoveries and suppositions used to get them. Interviewees are drawn closer from driving organizations over the esteem chain including providers, innovation suppliers, area specialists,and purchasers in order to guarantee an all-encompassing and fair photo of the market. Essential meetings help in information approval, as well as give basic bits of knowledge into the market, current business situation and future desires and upgrade the nature of our reports. Every one of our assessments and figure is checked through comprehensive essential research with Key Industry Participants (KIPs) which ordinarily include:
Preliminary Investigation
This is the closing phase in estimating and forecasting for our reports. In this stage face to face and telephonic exhaustive interviews are conducted to validate our conclusion and assumptions used to obtain the final data. The leading companies across the value chain including suppliers, technology providers, domain experts,and purchasers are approaching the interviewees to ensure a holistic and unbiased view of the market. These interviews are led over the world, with language boundaries defeat with the guide of local staff and translators. Primary interviews in information validation as well as give critical insights into the market, current business outline and future expectations upgrade the quality of our reports. All our estimates and forecast are verified through exhaustive primary research with Key Industry Participants include
Leading market organizations
The key targets of primary research are as per the following:
To validate our data as far as exactness and adequacy
To pick up an understanding into the present market and future desires
Select License
Payment
Why Choose Us
